Skip to main content
. Author manuscript; available in PMC: 2021 Jun 2.
Published in final edited form as: Anticancer Res. 2017 Sep;37(9):4873–4879. doi: 10.21873/anticanres.11896

Table III.

Multivariate survival analysis of DFS and OS.

DFS
OS
Hazard ratio [95%CI] p-Value Hazard ratio [95%CI] p-Value

FIGO stage (≥ IIB) 3.67 [1.54–8.75] 0.003 1.92 [0.56–6.59] 0.298
Tumor size (> 4 cm) 0.78 [0.34–1.80] 0.567 1.01 [0.31–3.22] 0.982
LN metastasis (positive) 5.26 [2.08–13.27] <0.001 6.08 [1.67–22.10] 0.006
BIM (high expression) 0.22 [0.07–0.65] 0.006 0.46 [0.01–0.96] 0.046

FIGO: International Federation of Gynecology and Obstetrics; LN: lymph nodes.